Literature DB >> 9111829

Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.

J M Weinberg1, J T Wolfe, S Sood, M Saruk, A H Rook, E M Spiers.   

Abstract

Interferons are cytokines produced by cells in response to stimulation by certain antigens and infectious agents. In recent years, recombinant interferons have been developed, which have antiviral, antiproliferative, and immunomodulatory functions. Several cutaneous reactions have been reported, including cutaneous ulceration at injection sites. We now report three cases of cutaneous ulceration caused by interferon beta-1b injections. In addition, we review all of the previously reported cases of cutaneous ulceration caused by recombinant interferons and discuss the different mechanisms by which these substances may produce this effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111829     DOI: 10.2340/00015555577146148

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Mononeuropathy following subcutaneous interferon-beta injection.

Authors:  M Capasso; M Caulo; G De Luca; N Magarelli; A Lugaresi
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 2.  Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.

Authors:  Barry G W Arnason
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 3.  Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Authors:  A Bayas; P Rieckmann
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

5.  Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.

Authors:  Gita Faghihi; Akram Basiri; Mohsen Pourazizi; Bahareh Abtahi-Naeini; Ali Saffaei
Journal:  J Res Pharm Pract       Date:  2015 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.